ARTIVA BIOTHERAPEUTICS SHARES DOWN 30% PREMARKET; CO DISCONTINUES CELL THERAPY AFTER TWO PATIENT DEATHS, CUTS WORKFORCE BY 94%

Reuters · 3d ago

Please log in to view news